Navigation Links
Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
Date:2/22/2008

COSTA MESA, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Bio-Clean International, Inc. (Pink Sheets: BCLN) announced today that the Company will be a presenter at an investment forum presented by Bluechip Capital, Inc., which is being held on February 27, 2008 at the Mission Bay Hilton in San Diego, California.

James E. Shipley, President and CEO of Bio-Clean International stated: "The Bluechip Capital investment forum will provide our Company an opportunity to present our compelling story to the investor community. The role our subsidiary companies have played in supplying environmentally-safe weapons cleaning products and equipment to the U.S. Military for over a decade has remained mostly untold. Our recent acquisition of these companies and their exclusive, eco-friendly technologies means that we can provide a platform to expand the public awareness of the unique bio-remedial cleaning systems we now offer. Our increased sales and marketing efforts are yielding great success. The Bluechip Capital investment forum will open up other doors, giving us access to a wide-range of individual and institutional investors."

About Bio-Clean International, Inc.

Bio-Clean International, Inc. recognizes the problems facing our environment. Our exclusive, non-toxic, bio-remediation fluids provide an environmentally-safe solution. Our exclusive products and machines have been tested and shown to be in complete compliance with environment regulations, in other words, "Cleantech".

Our majority-owned subsidiary, American Bio-Tech Cleaning, Inc. (ABT), designs and manufactures customized parts and weapons washing/cleaning systems that are eco-friendly, using a water-based cleaning fluid integrated with a self-contained bio-remediation process. We also own a minority interest in American Bio-Clean Corporation (ABC,) which markets and distributes our cleaning fluids and parts/weapons cleaning machines. ABC is a Service Disabled Veteran Owned Business (SDVOB) that is certified and meets the Federal-mandated 3% minority spending requirements. Similar mandated spending requirements adopted by most states vary from 3% to 20%. Additionally, many private sector companies have targeted goals for suppliers.

For more information about Bio-Clean International, Inc. please visit our website, http://www.bio-cleanintl.com.

A number of statements referenced in this Release, and any other interviews that have been made, are forward-looking statements, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not statements of historical fact and may be "forward-looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this actions may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions "may, "could," or "might," occur. Such statements reflect the current views of the company's management with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful closing of acquisition transactions and their subsequent integration, the ability to secure additional sources of financing, the ability to reduce operating expenses, and other factors described in the Company's filings with the Pink Sheets. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. The Company does not undertake any responsibility to update the "forward-looking" statements contained in this news release.


'/>"/>
SOURCE Bio-Clean International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
2. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
3. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
4. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
6. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Avicena Group to Present at Noble Financial Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):